EGFR and breast cancer: CEER was used to detect the expression and activation (phosphorylation) of HER1 and HER2, receptor members of the ErbB-RTK family, at a sensitivity level of a single cell in breast cancer cell lines, MDA-MB-468 and SKBr3, respectively (Figure 2a).